Search by Algolia
Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
GENELUX CorpGenelux Corporation Reports Q1 2025 Financial Results with $7.5 Million Net Loss
Upstart Holdings, Inc.Upstart Holdings Reports 67% Revenue Growth to $213.4 Million in Q1 2025
RIGEL PHARMACEUTICALS INCRigel Pharmaceuticals Reports 80% Revenue Growth to $53.3 Million in Latest Quarter
A10 Networks, Inc.A10 Networks Reports 9% Revenue Growth to $66.1 Million, Completes Acquisition of ThreatX Protect
SI-BONE, Inc.SI-BONE Reports 25% Revenue Growth to $47.3 Million in Q1 2025
HarborOne Bancorp, Inc.HarborOne Bancorp Reports $5.5 Million Net Income in Q1 2025, Announces Merger with Eastern Bankshares
WK Kellogg CoWK Kellogg Co Reports Decline in Net Sales and Profitability in Q1 2025
IDEAYA Biosciences, Inc.IDEAYA Biosciences Reports $72.2 Million Net Loss in Q1 2025 Amid Increased R&D Spending
WideOpenWest, Inc.WideOpenWest Reports 7% Revenue Decline but Improved Income from Operations in Q1 2025
TopBuild CorpTopBuild Reports Q1 2025 Financial Results with Decreased Net Income and Sales
Day One Biopharmaceuticals, Inc.Day One Biopharmaceuticals Reports $30.8M Revenue in Q1 2025, Significant Loss Reduction
TIGO ENERGY, INC.Tigo Energy Reports 92.2% Revenue Growth to $18.8 Million in Latest Quarter
Lifevantage CorpLifeVantage Corporation Reports 21.5% Revenue Growth to $58.4 Million in Latest Quarter
Adeia Inc.Adeia Inc. Reports $87.7 Million Revenue and $11.8 Million Net Income in Q1 2025
Denali Therapeutics Inc.Denali Therapeutics Reports $132.97 Million Net Loss in Q1 2025, Increases R&D Spending
VERTEX PHARMACEUTICALS INC / MAVertex Pharmaceuticals Reports $2.77 Billion Revenue, Net Income Declines 41%
Voyager Therapeutics, Inc.Voyager Therapeutics Reports $31M Net Loss and Decline in Collaboration Revenue in Q1 2025
Uniti Group Inc.Uniti Group Reports Q1 2025 Revenue Growth to $293.9 Million, Net Income Declines
BIOCRYST PHARMACEUTICALS INCBioCryst Pharmaceuticals Reports 57% Revenue Growth to $145.5 Million in Q1 2025
TransDigm Group INCTransDigm Reports 12% Revenue Growth to $2.15 Billion in Q2 Fiscal 2025
Keros Therapeutics, Inc.Keros Therapeutics Reports $211.2 Million Revenue and $148.5 Million Net Income in Q1 2025
CEDAR REALTY TRUST, INC.Cedar Realty Trust Reports 15.4% Revenue Decline but Significant Net Income Increase in Q1 2025
DigitalOcean Holdings, Inc.DigitalOcean Reports 14% Revenue Growth to $210.7 Million in Q1 2025
GLOBAL PAYMENTS INCGlobal Payments Reports Q1 2025 Results with Revenue Decline and Profitability Increase
Walker & Dunlop, Inc.Walker & Dunlop Reports 4% Revenue Growth but 77% Decline in Net Income for Q1 2025